Skip to main content
Premium Trial:

Request an Annual Quote

Source MDx Liquidating Assets

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) — Source Precision Medicine, dba SourceMDx, said today that it has assigned all its assets to Joseph Finn of accounting firm Finn, Warnke & Gayton for liquidation.

Source MDx has gone out of business and its intellectual property and patents will be sold at a sealed bid sale on April 29 at noon. The liquidation is being conducted for the benefits of Source MDx's creditors.

Source MDx was based in Boulder, Colo., and was developing blood-based tests that measured RNA transcripts for the presence and aggressiveness of cancer. It had been developing a test for prostate cancer and lung cancer, and collaborated with Pfizer on companion diagnostics for the drug manufacturer's cancer and inflammation therapeutic development programs.

In 2008, the company also formed a partnership with Brigham and Women's Hospital to study RNA-based biomarkers for multiple sclerosis.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.